Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Status: Unknown status Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20072
20081
20101
20111
20131
20141
20162
20191
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University2
Baylor Research Institute1
Beijing InnoCare Pharma Tech Co., Ltd.1
Charite University, Berlin, Germany1
Chronic Lymphocytic Leukemia Research Consortium1
Drugs for Neglected Diseases1
First Affiliated Hospital of Zhejiang University1
Fundación Teófilo Hernando, Spain1
Hong Kong Baptist University1
Hospital Universitario Dr. Jose E. Gonzalez1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome18
Leukemia3
Graft vs Host Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Pain2
Arthritis, Reactive1
Chagas Disease1
Complex Regional Pain Syndromes1
Hematologic Neoplasms1
Hodgkin Disease1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.